Dmitry 'Dima' Kuzmin
About Dmitry 'Dima' Kuzmin
Dmitry 'Dima' Kuzmin is an Assistant Professor Adjunct of Medicine at Yale University and Chairman at Hornet Therapeutics, with extensive experience in biotechnology and medicine. He has held various positions in academia and industry, focusing on areas such as structural biology, neurochemistry, and gene therapy.
Work at Yale University
Dmitry Kuzmin serves as an Assistant Professor Adjunct of Medicine at Yale University, a position he has held since 2021. His role involves contributing to the academic and research missions of the institution, focusing on areas related to medicine. Yale University is known for its strong emphasis on research and education in the medical field, providing a collaborative environment for faculty and students.
Current Positions in Biotechnology
Kuzmin holds several significant roles in the biotechnology sector. He is the Chairman of Hornet Therapeutics, a position he has occupied since 2022. Additionally, he serves as a Managing Partner at 4BIO Capital since 2014, and as a Board Member for multiple organizations, including Code Biotherapeutics and Ray Therapeutics, Inc. His involvement in these companies highlights his active participation in advancing biotechnological innovations.
Educational Background and Expertise
Dmitry Kuzmin has a robust educational background in the life sciences. He earned a PhD in Neurochemistry from Lomonosov Moscow State University from 2008 to 2011. He also completed an MSc in Experimental Therapeutics at the University of Oxford from 2016 to 2018. His academic training includes a focus on structural biology, neurochemistry, systems neuroscience, brain-computer interfaces, and gene therapy.
Previous Research Experience
Kuzmin has a diverse research background, having worked at renowned institutions. He was a Visiting Graduate Scholar at the Max Planck Institute for Brain Research from 2007 to 2008 and later served as a Postdoctoral Research Fellow at UCL from 2012 to 2017. His early research experience includes roles at the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry and the N.N. Blokhin Russian Cancer Research Center, where he contributed to various projects in biochemistry and neuroscience.
Involvement in Kauffman Fellows Program
Dmitry Kuzmin participated in the Kauffman Fellows Program, where he graduated in 2023. This program is designed to foster leadership in the venture capital and entrepreneurship sectors, emphasizing the importance of innovation in biotechnology and healthcare. His involvement reflects his commitment to advancing his expertise and network within the entrepreneurial landscape.